The Efficacy of Laparoscopic Sacrocolpopexy in the Treatment of Pelvic Organ Prolapse in Women With or Without Avulsion of the Levator Ani Muscle
1 other identifier
observational
120
1 country
2
Brief Summary
Based on a prospective study, to evaluate how pre-operative pelvic floor status - the presence of injury to the musculus levator ani - may influence the results of laparoscopic sacrocolpopexy. The investigators hope to confirm or disprove the hypothesis that the presence of such injury increases the risk of post-operative prolapse recurrence
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2014
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 10, 2015
CompletedFirst Posted
Study publicly available on registry
February 9, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFebruary 9, 2017
February 1, 2017
3.2 years
December 10, 2015
February 8, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Objective cure rate
The objective cure will be defined as absence of pelvic organ prolapse. Number of failures in each group: failure is defined as pelvic organ prolapse stage II or higher using the POPQ system during the clinical examination, or as a descent 1 cm below the lower edge of the pubic bone based on ultrasound examination
One year
Secondary Outcomes (10)
Genital hiatus size
One year
Distance of mesh from the bladder neck
One year
Lowest position of the mesh
One year
ICIQ-UI SF
One year
PISQ 12
One year
- +5 more secondary outcomes
Study Arms (2)
With levator ani avulsion
Patients indicated for sacrocolpopexy for pelvic organ prolapse and suffering with levator ani avulsion
Without levator ani avulsion
Patients indicated for sacrocolpopexy for pelvic organ prolapse and without levator ani avulsion
Interventions
standard laparoscopic sacrocolpopexy for prolapse treatment
Eligibility Criteria
Age over 18, symptomatic pelvic organ prolapse stage II or higher (according to the International Continence Society Pelvic Organ Prolapse quantification system - POPQ) in anterior and apical (central) compartment
You may qualify if:
- Age over 18
- signed informed consent
- symptomatic pelvic organ prolapse stage II or higher (according to the International Continence Society Pelvic Organ Prolapse quantification system - POPQ) in anterior and apical (central) compartment
- agreement with postoperative follow-up
You may not qualify if:
- Previous pelvic reconstructive mesh surgery
- Isolated posterior compartment prolapse
- Previous radiotherapy in lesser pelvis
- Contraindication of laparoscopic sacrocolpopexy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
General University Hospital
Prague, Prague, 12800, Czechia
Vladimir Kalis
Pilsen, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jaromir Masata, MD, Ph.D.
Charles University, Czech Republic
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Kamil Svabik, MD, Ph.D.
Study Record Dates
First Submitted
December 10, 2015
First Posted
February 9, 2017
Study Start
October 1, 2014
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
February 9, 2017
Record last verified: 2017-02